Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Assets Average: 2013-2025

Historic Assets Average for Agios Pharmaceuticals (AGIO) over the last 12 years, with Sep 2025 value amounting to $1.4 billion.

  • Agios Pharmaceuticals' Assets Average rose 11.39% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 11.39%. This contributed to the annual value of $1.3 billion for FY2024, which is 19.51% up from last year.
  • As of Q3 2025, Agios Pharmaceuticals' Assets Average stood at $1.4 billion, which was down 5.61% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Agios Pharmaceuticals' Assets Average registered a high of $2.2 billion during Q2 2021, and its lowest value of $811.4 million during Q2 2024.
  • Over the past 3 years, Agios Pharmaceuticals' median Assets Average value was $1.2 billion (recorded in 2023), while the average stood at $1.2 billion.
  • Per our database at Business Quant, Agios Pharmaceuticals' Assets Average spiked by 145.68% in 2021 and then crashed by 40.68% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Assets Average (Quarterly) stood at $1.5 billion in 2021, then decreased by 18.80% to $1.2 billion in 2022, then decreased by 19.62% to $972.2 million in 2023, then soared by 77.69% to $1.7 billion in 2024, then climbed by 11.39% to $1.4 billion in 2025.
  • Its Assets Average was $1.4 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.6 billion in Q1 2025.